Pfizer beats 3Q net forecasts on lower charges, higher sales

Pfizer doubled its third-quarter profit, on a combination of slightly higher sales, lower one-time charges and reduced spending on production and administration. The drug giant edged past Wall Street's profit expectations and improved its 2017 financial forecast.

from Biotech News